WO2023059047A1 - Composition for preventing or treating hair loss, comprising samdachal-jo (jeju glutinous millet) extract - Google Patents
Composition for preventing or treating hair loss, comprising samdachal-jo (jeju glutinous millet) extract Download PDFInfo
- Publication number
- WO2023059047A1 WO2023059047A1 PCT/KR2022/014951 KR2022014951W WO2023059047A1 WO 2023059047 A1 WO2023059047 A1 WO 2023059047A1 KR 2022014951 W KR2022014951 W KR 2022014951W WO 2023059047 A1 WO2023059047 A1 WO 2023059047A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extract
- hair loss
- perilla
- samda
- dermal papilla
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 66
- 201000004384 Alopecia Diseases 0.000 title claims abstract description 50
- 208000024963 hair loss Diseases 0.000 title claims abstract description 45
- 230000003676 hair loss Effects 0.000 title claims abstract description 38
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 244000062793 Sorghum vulgare Species 0.000 title abstract description 4
- 235000019713 millet Nutrition 0.000 title abstract description 4
- 230000002500 effect on skin Effects 0.000 claims abstract description 63
- 230000035755 proliferation Effects 0.000 claims abstract description 27
- 235000013305 food Nutrition 0.000 claims abstract description 18
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 13
- 241000229722 Perilla <angiosperm> Species 0.000 claims description 50
- 235000004347 Perilla Nutrition 0.000 claims description 49
- 239000000469 ethanolic extract Substances 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 20
- 239000002021 butanolic extract Substances 0.000 claims description 17
- 230000002265 prevention Effects 0.000 claims description 15
- 238000011282 treatment Methods 0.000 claims description 13
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 12
- 241000195493 Cryptophyta Species 0.000 claims description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- 230000003752 improving hair Effects 0.000 claims description 8
- 241000218645 Cedrus Species 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 230000006872 improvement Effects 0.000 claims description 5
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 4
- 239000012046 mixed solvent Substances 0.000 claims description 4
- 235000020710 ginseng extract Nutrition 0.000 claims description 3
- 230000001965 increasing effect Effects 0.000 abstract description 19
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 45
- 230000000694 effects Effects 0.000 description 38
- 230000004663 cell proliferation Effects 0.000 description 27
- 210000004209 hair Anatomy 0.000 description 14
- 239000013641 positive control Substances 0.000 description 14
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 13
- 229960003632 minoxidil Drugs 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000002035 hexane extract Substances 0.000 description 10
- 239000002026 chloroform extract Substances 0.000 description 8
- 239000002024 ethyl acetate extract Substances 0.000 description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 230000002062 proliferating effect Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000003779 hair growth Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 230000003698 anagen phase Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- JWJOTENAMICLJG-QWBYCMEYSA-N dutasteride Chemical compound O=C([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)N[C@@H]4CC3)C)CC[C@@]21C)NC1=CC(C(F)(F)F)=CC=C1C(F)(F)F JWJOTENAMICLJG-QWBYCMEYSA-N 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000031774 hair cycle Effects 0.000 description 3
- 239000012454 non-polar solvent Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000003135 vibrissae Anatomy 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 240000005498 Setaria italica Species 0.000 description 2
- 235000007226 Setaria italica Nutrition 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 206010068168 androgenetic alopecia Diseases 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 229960004199 dutasteride Drugs 0.000 description 2
- -1 etc.) Chemical compound 0.000 description 2
- 229960004039 finasteride Drugs 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 description 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000003024 Diffuse alopecia Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 102000004257 Potassium Channel Human genes 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940054749 avodart Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 231100000013 eye irritation Toxicity 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000003660 hair regeneration Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 108020001213 potassium channel Proteins 0.000 description 1
- 239000004036 potassium channel stimulating agent Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940117382 propecia Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229940107889 rogaine Drugs 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 201000001297 telogen effluvium Diseases 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a composition for preventing, treating, or alleviating hair loss, comprising a Samdachal-jo (Jeju glutinous millet) extract. Specifically, the present invention relates to a pharmaceutical composition or a food composition for preventing, treating, or alleviating hair loss by increasing the proliferation of dermal papilla cells, the composition comprising a Samdachal-jo extract as an active ingredient.
Description
본 발명은 삼다차조 추출물을 포함하는 탈모의 예방, 치료 또는 개선을 위한 조성물에 관한 것이다. 구체적으로, 본 발명은 삼다차조 추출물을 유효성분으로 포함하는, 모유두 세포의 증식을 증가시켜 탈모를 예방, 치료 또는 개선하기 위한 약학 조성물 또는 식품 조성물에 관한 것이다.The present invention relates to a composition for preventing, treating, or improving hair loss comprising an extract of cedar algae. Specifically, the present invention relates to a pharmaceutical composition or a food composition for preventing, treating, or improving hair loss by increasing the proliferation of dermal papilla cells, comprising an extract of Samdacha algae as an active ingredient.
모유두 세포는 모발의 발생과 성장을 담당하는 핵심 세포로, 모발의 피하에 있는 뿌리인 모근의 가장 밑부분에 위치한다. 실제로 두피에서 모유두 세포를 채집해 배양 후 이식할 경우 모발이 새로 자라난다. 하지만 모유두 세포를 탈모 치료제로 사용하기에는 여러 어려움이 존재한다. 우선 두피로부터의 분리가 어렵고, 배양 조건이 까다로우며 충분한 양의 세포를 배양하는 것이 어렵다. 또한 많이 배양할 경우 모발 재생 능력이 현저히 저하되는 한계가 있다.Dermal papilla cells are key cells responsible for the development and growth of hair, and are located at the bottom of the hair root, which is the root of the hair subcutaneously. In fact, when dermal papilla cells are collected from the scalp, cultured, and transplanted, new hair grows. However, there are several difficulties in using dermal papilla cells as a hair loss treatment. First, it is difficult to separate from the scalp, the culture conditions are difficult, and it is difficult to culture a sufficient amount of cells. In addition, when cultured a lot, there is a limit in that the hair regeneration ability is significantly lowered.
사람의 모발은 일정한 모발 성장주기 (hair growth cycle)를 가지고 있기 때문에 항상 일정한 수의 모발을 유지하게 된다. 그러나 탈모가 진행되면 모근에 존재하는 모유두가 작아지고, 모유두가 작아지면 머리털의 굵기가 가늘어지고, 동시에 모발 성장주기도 짧아진다. 따라서 탈모가 진행되면 머리털은 매우 가늘어지며 모발 성장주기는 더욱 짧아져 조금 자란 후 빠지게 된다.Since human hair has a certain hair growth cycle, a certain number of hairs is always maintained. However, as hair loss progresses, the dermal papilla present in the hair root becomes smaller, and when the dermal papilla becomes smaller, the thickness of the hair becomes thinner, and at the same time, the hair growth cycle is shortened. Therefore, as hair loss progresses, the hair becomes very thin and the hair growth cycle becomes shorter, so it grows a little and then falls out.
탈모의 원인으로는 유전적인 원인, 남성호르몬의 작용뿐만 아니라 내분비 질환, 영양 결핍, 약물 사용, 출산, 발열, 수술 등의 심한 신체적, 정신적 스트레스 등의 요인들이 복합적으로 작용하는 것으로 알려져 있다. 최근에는 남성형 탈모뿐만 아니라 식생활의 변화, 사회 환경 등에 의한 스트레스의 증가로 인해 여성의 탈모 인구도 증가하고 있는 추세이며, 연령 또한 낮아지고 있다.It is known that the cause of hair loss is a combination of factors such as genetic causes and male hormones, as well as severe physical and mental stress such as endocrine diseases, nutritional deficiencies, drug use, childbirth, fever, and surgery. In recent years, not only male pattern baldness, but also the trend of increasing the female hair loss population due to changes in dietary life, increase in stress due to social environment, etc., and the age is also getting lower.
현재 가장 빈번하게 쓰이는 탈모 치료제로는 피나스테라이드 (finasteride; 상품명 Propecia®), 두타스테라이드 (dutasteride; 상품명 Avodart®), 미녹시딜 (minoxidil; 상품명 마이녹실® 또는 Rogaine®) 등이 있다. 피나스테라이드와 두타스테라이드는 5α-환원효소 억제제 (5α-reductase inhibitor)로 남성호르몬 (testosterone)이 5α-dihydrotestosterone (DHT)로 전환되는 것을 억제한다. 그러나 이 제품은 성욕감퇴, 발기부전, 운전 및 수행능력 상실 등의 부작용을 나타낸다. 한편 미녹시딜의 경우 아직까지 그 기전이 완벽히 밝혀지지 않았으나, 세포막을 과분극 (hyperpolarization)시키는 칼륨 채널 개방제 (potassium chaennel opener)로서, 혈관 확장 및 칼륨 채널 개방을 통해, 모낭에 산소, 혈액, 영양소 등의 공급을 증가시켜 모낭을 건강하게 하는 것으로 여겨지고 있다. 그러나 이 제품 역시 도포 부위의 가려움, 홍반, 피부 자극, 눈의 자극 등의 부작용이 나타나며, 머리 이외에 다른 신체 부위에서의 원치 않는 모발의 성장이 관찰되기도 한다. 이러한 기존 제품들의 부작용은 환자들의 불안감을 증폭시키고 심할 경우 투여 거부까지 이어질 수 있기 때문에 부작용이 적은 약물을 개발하려는 노력이 계속되고 있다.Currently, the most frequently used hair loss treatments include finasteride (trade name Propecia®), dutasteride (trade name Avodart®), and minoxidil (trade name Minoxidil® or Rogaine®). Finasteride and dutasteride are 5α-reductase inhibitors that inhibit the conversion of testosterone to 5α-dihydrotestosterone (DHT). However, this product shows side effects such as decreased libido, erectile dysfunction, and loss of ability to drive and perform. On the other hand, in the case of minoxidil, its mechanism has not yet been fully elucidated, but as a potassium channel opener that hyperpolarizes cell membranes, it expands blood vessels and opens potassium channels, thereby providing oxygen, blood, and nutrients to hair follicles. It is believed to make hair follicles healthy by increasing their supply. However, this product also has side effects such as itchiness, erythema, skin irritation, and eye irritation at the application site, and unwanted hair growth in other parts of the body other than the head is sometimes observed. Since the side effects of these existing products can amplify patients' anxiety and lead to refusal of administration in severe cases, efforts to develop drugs with fewer side effects are continuing.
한편, 삼다차조는 제주지역 토종 차조로, 곡물인 조 (Setaria italica)의 품종의 일종이다. 한국 등록특허공보 제10-2150927호에 삼다차조 혼합 추출물의 항염 효과, 피부 보습 효과, 피부 장벽 강화 효과 및 아토피 개선 효과를 개시하고 있으나, 삼다차조 추출물의 탈모 개선 효과에 대해서 전혀 개시되어 있지 않다.On the other hand, Samdachajo is a native Jeju region, and is a kind of grain of millet ( Setaria italica ). Although Korean Patent Registration No. 10-2150927 discloses the anti-inflammatory effect, skin moisturizing effect, skin barrier strengthening effect, and atopy improving effect of the mixed extract of Samda algae, the effect of improving hair loss of the Samda alga extract is not disclosed at all.
따라서, 본 발명자들은 부작용이 적으면서 우수한 탈모의 예방 및 치료 효과를 갖는 물질을 연구하는 과정에서 삼다차조 추출물이 모유두 세포를 증식하는 효능을 갖는 것을 발견하여 본 발명을 완성하였다.Therefore, the inventors of the present invention completed the present invention by discovering that the Samda perilla extract has an effect of proliferating dermal papilla cells in the process of researching a substance having excellent preventive and therapeutic effects on hair loss with few side effects.
[선행기술문헌][Prior art literature]
[특허문헌][Patent Literature]
(특허문헌 1) 한국 등록특허공보 제10-2150927호(Patent Document 1) Korean Patent Registration No. 10-2150927
본 발명은 삼다차조 추출물을 포함하는 탈모의 예방 또는 치료를 위한 약학 조성물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a pharmaceutical composition for the prevention or treatment of hair loss containing an extract of cedar algae.
또한, 본 발명은 삼다차조 추출물을 포함하는 탈모의 예방 또는 개선을 위한 식품 조성물을 제공하는 것을 목적으로 한다.In addition, an object of the present invention is to provide a food composition for the prevention or improvement of hair loss containing the extract of cedar algae.
본 발명은 삼다차조 추출물을 포함하는 탈모의 예방 또는 치료를 위한 약학 조성물을 제공한다.The present invention provides a pharmaceutical composition for the prevention or treatment of hair loss containing the extract of cedar algae.
또한, 본 발명은 삼다차조 추출물을 포함하는 탈모의 예방 또는 개선을 위한 식품 조성물을 제공한다.In addition, the present invention provides a food composition for the prevention or improvement of hair loss containing the extract of Samdachajo.
상기 삼다차조 추출물은 물, C1 내지 C6의 알코올, 에틸아세테이트, 헥산, 클로로포름, 및 이들의 혼합 용매로 이루어지는 군으로부터 선택되는 용매로 추출될 수 있으며, 이에 제한되지 않는다.The Samdachajo extract may be extracted with a solvent selected from the group consisting of water, C1 to C6 alcohol, ethyl acetate, hexane, chloroform, and mixed solvents thereof, but is not limited thereto.
바람직하게, 본 발명의 삼다차조 추출물은 0.01% 내지 90% 에탄올 추출물 또는 부탄올 추출물일 수 있으며, 더욱 바람직하게 본 발명의 삼다차조 추출물은 60% 내지 80% 에탄올 추출물 또는 부탄올 추출물일 수 있고, 가장 바람직하게 본 발명의 삼다차조 추출물은 70% 에탄올 추출물 또는 부탄올 추출물일 수 있다.Preferably, the Samda perilla extract of the present invention may be 0.01% to 90% ethanol extract or butanol extract, more preferably, the Samda perilla extract of the present invention may be 60% to 80% ethanol extract or butanol extract, and most preferably Preferably, the extract of Samdachajo of the present invention may be a 70% ethanol extract or a butanol extract.
본 발명의 삼다차조 추출물은 모유두 세포의 증식을 증가시켜 탈모를 예방, 치료 또는 개선할 수 있다.The extract of Samdachajo of the present invention can prevent, treat, or improve hair loss by increasing the proliferation of dermal papilla cells.
본 발명의 삼다차조 추출물을 유효성분으로 포함하는 조성물은 모유두 세포의 증식을 촉진시켜 모발의 성장기를 유도하는 효과를 가지면서 부작용이 적어, 모발의 성장 또는 탈모의 개선에 효과적으로 사용될 수 있다.The composition containing the extract of Samdacha algae of the present invention as an active ingredient promotes the proliferation of dermal papilla cells to induce the growth phase of hair, while having few side effects, so it can be effectively used to improve hair growth or hair loss.
도 1은 삼다차조 70% 에탄올 추출물에 대한 모유두 세포의 증식 효과를 측정한 결과를 나타낸다.Figure 1 shows the results of measuring the proliferation effect of dermal papilla cells for 70% ethanol extract of Samda perilla.
도 2는 삼다차조 헥산 추출물에 대한 모유두 세포의 증식 효과를 측정한 결과를 나타낸다.Figure 2 shows the results of measuring the proliferation effect of dermal papilla cells for the hexane extract of Samdachajo.
도 3은 삼다차조 에틸아세테이트 추출물에 대한 모유두 세포의 증식 효과를 측정한 결과를 나타낸다.Figure 3 shows the results of measuring the proliferation effect of dermal papilla cells for the ethyl acetate extract of Samda perilla.
도 4는 삼다차조 클로로포름 추출물에 대한 모유두 세포의 증식 효과를 측정한 결과를 나타낸다.Figure 4 shows the results of measuring the proliferation effect of dermal papilla cells for the chloroform extract of Samda perilla.
도 5는 삼다차조 부탄올 추출물에 대한 모유두 세포의 증식 효과를 측정한 결과를 나타낸다.Figure 5 shows the results of measuring the proliferation effect of dermal papilla cells for the butanol extract of Samda perilla.
도 6은 삼다차조 열수 추출물에 대한 모유두 세포의 증식 효과를 측정한 결과를 나타낸다.Figure 6 shows the results of measuring the proliferation effect of dermal papilla cells on the hot water extract of Samdachajo.
도 7은 차조 70% 에탄올 추출물에 대한 모유두 세포의 증식 효과를 측정한 결과를 나타낸다.Figure 7 shows the results of measuring the proliferation effect of dermal papilla cells for the perilla 70% ethanol extract.
도 8은 차조 열수 추출물에 대한 모유두 세포의 증식 효과를 측정한 결과를 나타낸다.Figure 8 shows the results of measuring the proliferation effect of dermal papilla cells on the perilla hot water extract.
이하, 첨부한 도면을 참조하여 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 본원의 실시태양 및 실시예를 상세히 설명한다. 그러나 본원은 여러 가지 형태로 구현될 수 있으며 여기에서 설명하는 실시태양 및 실시예에 한정되지 않는다.Hereinafter, with reference to the accompanying drawings, embodiments and examples of the present disclosure will be described in detail so that those skilled in the art can easily practice the present invention. However, the present application may be implemented in various forms and is not limited to the embodiments and examples described herein.
본원 명세서 전체에서, 어떤 부분이 어떤 구성 요소를 "포함" 한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성 요소를 제외하는 것이 아니라 다른 구성 요소를 더 포함할 수 있는 것을 의미한다.Throughout the present specification, when a part "includes" a certain component, it means that it may further include other components without excluding other components unless otherwise stated.
본 발명은 삼다차조 추출물을 포함하는 탈모의 예방 또는 치료를 위한 약학 조성물에 관한 것이다.The present invention relates to a pharmaceutical composition for the prevention or treatment of hair loss comprising an extract of cedar algae.
본 발명의 "탈모"는, 그 원인과 무관하게, 정상적으로 모발이 존재해야 할 부위에 모발이 없는 상태를 지칭하며, 원형 탈모, 유전성 안드로겐 탈모, 휴지기 탈모, 외상성 탈모, 발모벽, 압박성 탈모, 생장기 탈모, 비강성 탈모, 매독성 탈모, 지루 탈모, 증후성 탈모, 반흔성 탈모 또는 선천성 탈모일 수 있으나, 이에 제한되지 않는다."Hair loss" of the present invention refers to a condition in which there is no hair in an area where hair should normally exist, regardless of the cause, and includes circular alopecia, hereditary androgenetic alopecia, telogen effluvium, traumatic alopecia, hair growth, pressure alopecia, It may be anagen hair loss, pityroid hair loss, syphilitic hair loss, seborrheic hair loss, symptomatic hair loss, scarring hair loss or congenital hair loss, but is not limited thereto.
본 발명의 삼다차조 (Setaria italica Beauv.)는 곡물인 조의 일종으로, 제주 지역에서 자생하는 토종 차조이며, 품종명은 삼다찰이다 (국립종자원 품종 참조). 본 발명에서는 제주도에서 자생하여 수확한 것인 삼다차조를 이용할 수 있으나 이에 한정되지 않는다.Samda chajo ( Setaria italica Beauv. ) of the present invention is a kind of millet, which is a grain, and is a native perilla native to the Jeju region, and the variety name is Samdachal (see National Seed Resources). In the present invention, it is possible to use Samda tea, which is harvested from Jeju Island, but is not limited thereto.
본 발명의 삼다차조 추출물은 모유두 세포의 증식을 촉진하여 모발의 성장기를 유도함으로써, 탈모를 예방 또는 치료하는 효과를 나타낼 수 있다.The ginseng extract of the present invention can exhibit the effect of preventing or treating hair loss by promoting the proliferation of dermal papilla cells and inducing the growth phase of hair.
본 발명의 "치료"는, 본 발명의 조성물의 투여로 탈모 진행이 지연 또는 멈춰 탈모 증세를 호전시키거나, 모발이 길어지거나 수가 많아지는 등의 발모 및 육모가 촉진되는 등의 탈모 증세를 이롭게 변경하는 모든 행위를 의미한다."Treatment" of the present invention is to improve the symptoms of hair loss by delaying or stopping the progress of hair loss by administering the composition of the present invention, or beneficially changing the symptoms of hair loss, such as promoting hair growth and hair growth, such as lengthening or increasing the number of hairs. means all actions
본 발명의 "예방"은 본 발명에 따른 조성물의 투여에 의해 탈모의 발병을 억제 또는 지연시키는 모든 행위를 의미하고, "개선"은 본 발명의 추출물을 포함하는 조성물의 투여로 치료되는 상태와 관련된 파라미터, 예를 들면 증상의 정도를 적어도 감소시키는 모든 행위를 의미한다."Prevention" of the present invention refers to any action that suppresses or delays the onset of hair loss by administration of the composition according to the present invention, and "improvement" is related to the condition treated by administration of the composition containing the extract of the present invention. Any action that at least reduces the severity of a parameter, eg a symptom.
본 발명의 "추출물"은 당업계에서 공지된 통상적인 추출용매를 이용하여 얻을 수 있다. 추출용매로는 극성 용매 또는 비극성 용매를 이용할 수 있다. 극성 용매로는 물, C1 내지 C6의 알코올 (예: 메탄올, 에탄올, 프로판올, 부탄올, 노말-프로판올, 이소-프로판올 및 노말-부탄올 등), 아세트산, 또는 상기 극성 용매들의 혼합물을 포함한다. 비극성 용매로는 아세톤, 아세토나이트릴, 에틸아세테이트, 메틸아세테이트, 부틸아세테이트, 플루오로알칸, 헥산, 에테르, 클로로포름, 디클로로메탄 또는 상기 비극성 용매들의 혼합물을 포함한다.The "extract" of the present invention can be obtained using a conventional extraction solvent known in the art. A polar solvent or a non-polar solvent may be used as the extraction solvent. Polar solvents include water, C1 to C6 alcohols (eg, methanol, ethanol, propanol, butanol, n-propanol, iso-propanol and n-butanol, etc.), acetic acid, or mixtures of the above polar solvents. Non-polar solvents include acetone, acetonitrile, ethyl acetate, methyl acetate, butyl acetate, fluoroalkanes, hexane, ether, chloroform, dichloromethane or mixtures of the above non-polar solvents.
일 실시태양에서, 상기 추출물은 물, C1 내지 C6의 알코올, 아세트산, 및 이들의 혼합 용매로 이루어지는 군으로부터 선택되는 용매로 추출된 것일 수 있다. 바람직하게는, 0.01% 내지 90% 에탄올 추출물 또는 부탄올 추출물이며, 더욱 바람직하게는 60% 내지 80% 에탄올 추출물 또는 부탄올 추출물이고, 가장 바람직하게는 70% 에탄올 추출물 또는 부탄올 추출물일 수 있다.In one embodiment, the extract may be extracted with a solvent selected from the group consisting of water, C1 to C6 alcohol, acetic acid, and a mixed solvent thereof. Preferably, it is 0.01% to 90% ethanol extract or butanol extract, more preferably 60% to 80% ethanol extract or butanol extract, and most preferably 70% ethanol extract or butanol extract.
본 발명의 추출물은 열수 추출, 냉침 추출, 환류 냉각 추출, 초음파 추출 또는 당업계에 알려진 통상적인 추출방법을 통해 추출한 것일 수 있다.The extract of the present invention may be extracted through hot water extraction, cold extraction, reflux cooling extraction, ultrasonic extraction, or a conventional extraction method known in the art.
본 발명에 사용된 용어 "추출물"은 당업계에서 조추출물 (crude extract)로 통용되는 것을 의미하지만, 광의적으로 추출물을 추가적으로 분획 (fractionation)한 분획물도 포함한다. 즉 추출물은 상술한 용매를 이용하여 얻은 것뿐만 아니라, 여기에 정제 과정을 추가적으로 적용하여 얻은 것을 포함한다. 예컨대, 상기 추출물을 일정한 분자량 컷-오프 값을 갖는 한외여과막을 통과시켜 얻은 분획, 다양한 크로마토그래프 (크기, 전하, 소수성 또는 친화성에 따른 분리를 위해 제작된 것)에 의한 분리 등, 추가적으로 실시된 다양한 정제 방법을 통해 얻어진 분획도 본 발명의 생약 추출물에 포함된다.The term "extract" used in the present invention means what is commonly used as a crude extract in the art, but also includes a fraction obtained by additional fractionation of the extract in a broad sense. That is, the extract includes not only those obtained using the above-described solvent, but also those obtained by additionally applying a purification process thereto. For example, a fraction obtained by passing the extract through an ultrafiltration membrane having a certain molecular weight cut-off value, separation by various chromatographs (designed for separation according to size, charge, hydrophobicity or affinity), etc. Fractions obtained through the purification method are also included in the crude drug extract of the present invention.
본 발명의 약학 조성물은 목적하는 방법에 따라 비경구투여 또는 경구 투여할 수 있으며, 투여량은 환자의 체중, 연령, 성별, 건강상태, 식이, 투여시간, 투여방법, 배설률 및 질환의 중증도 등에 따라 그 범위가 다양하다. 또한 상기 조성물의 치료적으로 유효한 양은 투여방법, 목적부위, 환자의 상태에 따라 달라질 수 있으며, 인체에 사용시 투여량은 안전성 및 효율성을 함께 고려하여 적정량으로 결정되어야 한다.The pharmaceutical composition of the present invention can be parenterally administered or orally administered according to the desired method, and the dosage depends on the patient's weight, age, sex, health condition, diet, administration time, administration method, excretion rate, and severity of the disease. Its range is diverse. In addition, the therapeutically effective amount of the composition may vary depending on the administration method, the target site, and the condition of the patient, and when used in the human body, the dosage should be determined in an appropriate amount in consideration of safety and efficiency.
본 발명은 삼다차조 조성물을 포함하는 탈모 예방 또는 개선용 식품 조성물에 관한 것이다. 상기 식품 조성물은 건강기능식품, 유제품, 발효제품 또는 식품 첨가물일 수 있다.The present invention relates to a food composition for preventing or improving hair loss comprising a samdachajo composition. The food composition may be a health functional food, dairy product, fermented product or food additive.
상기 "건강기능식품"은 인체에 유용한 기능성을 가진 원료나 성분을 사용하여 제조 및 가공한 식품을 의미하며, "기능성"은 인체의 구조 및 기능에 대하여 영양소를 조절하거나 생리학적 작용 등과 같은 보건 용도에 유용한 효과를 얻을 목적으로 섭취하는 것을 의미한다.The "health functional food" refers to food manufactured and processed using raw materials or ingredients having useful functionalities for the human body, and "functional" refers to health uses such as adjusting nutrients for the structure and function of the human body or physiological actions, etc. It means to take it for the purpose of obtaining a beneficial effect on it.
상기 "식품 첨가물"로서의 적합 여부는 다른 규정이 없는 한, 식품의약품안전처에 승인된 식품 첨가물 공전의 총칙 및 일반시험법 등에 따라 해당 품목에 관한 규격 및 기준에 의하여 판정한다.The suitability of the above "food additive" is determined according to the specifications and standards for the item in accordance with the general rules of the Food Additive Code and general test methods approved by the Ministry of Food and Drug Safety, unless otherwise specified.
일 실시태양에서 상기 식품 조성물은 여러 가지 영양제, 비타민, 광물 (전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제 (치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 추가로 포함할 수 있다.In one embodiment, the food composition is various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, colorants and enhancers (cheese, chocolate, etc.), pectic acid and its salts, alginic acid and It may further include salts thereof, organic acids, protective colloidal thickeners, pH adjusting agents, stabilizers, preservatives, glycerin, alcohol, carbonation agents used in carbonated beverages, and the like.
일 실시태양에서 상기 식품 조성물은 환제, 분말, 과립, 침제, 정제, 캡슐, 액제, 페이스트, 겔, 또는 젤리 등의 형태를 포함하며, 상기 조성물을 첨가할 수 있는 식품으로는, 예를 들어, 각종 식품류, 예를 들어, 음료, 껌, 차, 비타민 복합제, 건강보조 식품류 등이 있다.In one embodiment, the food composition includes a form such as a pill, powder, granule, precipitate, tablet, capsule, liquid, paste, gel, or jelly, and the food to which the composition can be added includes, for example, There are various types of foods, such as beverages, chewing gum, tea, vitamin complexes, health supplements, and the like.
상기 식품 조성물의 제형은 특별히 한정되지 않으나, 예를 들어, 정제, 과립제, 분말제, 드링크제와 같은 액제, 캐러멜, 겔, 바 등으로 제형화될 수 있다. 각 제형의 식품 조성물은 유효 성분 이외에 해당 분야에서 통상적으로 사용되는 성분들을 제형 또는 사용 목적에 따라 당업자가 어려움 없이 적의 선정하여 배합할 수 있다.The formulation of the food composition is not particularly limited, but may be formulated into, for example, tablets, granules, powders, liquids such as drinks, caramels, gels, bars, and the like. The food composition of each formulation can be formulated without difficulty by a person skilled in the art according to the formulation or purpose of use by selecting and blending ingredients commonly used in the field in addition to the active ingredient.
이하 실시예를 통하여 본 발명을 더욱 상세하게 설명하고자 하나, 하기의 실시예는 단지 설명의 목적을 위한 것이며 본원 발명의 범위를 한정하고자 하는 것은 아니다.The present invention will be described in more detail through the following examples, but the following examples are for illustrative purposes only and are not intended to limit the scope of the present invention.
[실시예 1] [Example 1]
추출물의 제조Preparation of extract
삼다차조 70% 에탄올 추출물, 삼다차조 열수 추출물, 삼다차조 헥산 추출물, 삼다차조 에틸아세테이트 추출물, 삼다차조 클로로포름 추출물, 삼다차조 부탄올 추출물, 차조 70% 에탄올 추출물 및 차조 열수 추출물을 준비하였다.Samda-chajo 70% ethanol extract, Samda-chajo hot water extract, Samda-chajo hexane extract, Samda-chajo ethyl acetate extract, Samda-chajo chloroform extract, Samda-chajo butanol extract, Samda-chajo 70% ethanol extract, and Samda-chajo hot-water extract were prepared.
[실시예 2] [Example 2]
흰쥐 수염 모유두 세포의 배양Culture of rat whisker dermal papilla cells
흰쥐 수염에서 분리된 모유두 세포를 불멸화한 세포 (Rat vibrissa immortalized dermal papilla cell: Filsell et al., 1994)를 100 units/mL penicillin-100 μg/mL streptomycin (Gibco Inc, NY, USA) 및 10% heat-inactivated fetal bovine serum (FBS; Gibco Inc, NY, USA)이 함유된 DMEM (Hyclone Inc, USA) 배지를 사용하여 37°C, 5% CO2 항온기에서 배양하였으며, 3일에 한 번씩 계대배양하였다.100 units/mL penicillin-100 μg/mL streptomycin (Gibco Inc, NY, USA) and 10% heat -Incubated in DMEM (Hyclone Inc, USA) medium containing inactivated fetal bovine serum (FBS; Gibco Inc, NY, USA) in a 37°C, 5% CO 2 incubator and subcultured once every 3 days. .
[실시예 3] [Example 3]
삼다차조 70% 에탄올 (EtOH) 추출물에 대한 모유두 세포의 증식 효과Effect of 70% ethanol (EtOH) extract of Samdachajo on the proliferation of dermal papilla cells
흰쥐 수염에서 분리된 모유두 세포를 불멸화한 세포 (Rat vibrissa immortalized dermal papilla cell)의 증식은 MTT assay를 이용하여 측정하였다. 모유두 세포 (1.0×104 cells/mL)를 1% FBS를 포함한 DMEM 배지에 혼탁하여 96 well plate에 넣고 24시간 배양하였다.Proliferation of rat vibrissa immortalized dermal papilla cells immortalized from dermal papilla cells isolated from rat whiskers was measured using the MTT assay. Dermal papilla cells (1.0×10 4 cells/mL) were turbid in DMEM medium containing 1% FBS, placed in a 96 well plate, and cultured for 24 hours.
삼다차조 70% 에탄올 추출물을 1, 10 및 25 μg/mL의 농도로 처리하였다. 양성 대조군으로 미녹시딜 (minoxidil, Sigma, MO, USA) 10 μM 농도로 처리하였다. 48시간 동안 배양한 후 10 μL의 WST dye (Daeil Lab Service, Seoul, Korea)을 첨가하고 3시간 동안 반응시켰다. VERSAmax microplate reader (Molecular Devices, CA, USA)를 사용하여 450 nm에서 흡광도를 측정하였다. 시료군에 대한 평균 흡광도 값을 구하였으며, 대조군의 흡광도 값과 비교하여 증식 정도를 조사하여, 하기 표 1 및 도 1에 나타내었다.Samdachajo 70% ethanol extract was treated at concentrations of 1, 10 and 25 μg/mL. As a positive control, minoxidil (Sigma, MO, USA) was treated with 10 μM concentration. After culturing for 48 hours, 10 μL of WST dye (Daeil Lab Service, Seoul, Korea) was added and reacted for 3 hours. Absorbance was measured at 450 nm using a VERSAmax microplate reader (Molecular Devices, CA, USA). The average absorbance value for the sample group was obtained, and the degree of proliferation was investigated in comparison with the absorbance value of the control group, and is shown in Table 1 and FIG. 1 below.
농도density | Cell proliferation (% of control)Cell proliferation (% of control) | |
대조군control group | -- | 100.0100.0 |
minoxidil (양성대조군)minoxidil (positive control) | 10 μM10 µM | 109.1109.1 |
삼다차조 70% EtOH 추출물Samda Perilla 70 |
1 μg/mL1 µg/mL | 104.3±2.9104.3±2.9 |
삼다차조 70% EtOH 추출물Samda Perilla 70 |
10 μg/mL10 µg/mL | 137.3±4.8137.3±4.8 |
삼다차조 70% EtOH 추출물Samda Perilla 70 |
25 μg/mL25 µg/mL | 144.1±6.2144.1±6.2 |
상기 표 1 및 도 1에 나타낸 바와 같이, 삼다차조 70% EtOH 추출물을 1, 10 및 25 μg/mL의 농도로 처리하였을 때, 농도가 증가할수록 모유두 세포의 증식이 증가하는 것을 확인하였다. 특히, 삼다차조 70% EtOH 추출물을 10 및 25 μg/mL 농도로 처리한 경우, 대조군에 비하여 모유두 세포의 성장이 유의하게 증가하였으며, 양성대조군의 세포 증식 측정 결과보다 현저하게 높은 모유두 세포 증식 효과를 나타내었다.As shown in Table 1 and FIG. 1, when the 70% EtOH extract of Samdachajo was treated at concentrations of 1, 10, and 25 μg/mL, it was confirmed that the proliferation of dermal papilla cells increased as the concentration increased. In particular, when the Samda perilla 70% EtOH extract was treated at concentrations of 10 and 25 μg/mL, the growth of dermal papilla cells was significantly increased compared to the control group, and the dermal papilla cell proliferation effect was significantly higher than that of the positive control group. showed up
따라서, 삼다차조 70% 에탄올 추출물은 모유두 세포 증식 효능을 갖는 것을 알 수 있다.Therefore, it can be seen that the 70% ethanol extract of Samdachajo has a dermal papilla cell proliferation effect.
[실시예 4] [Example 4]
삼다차조 헥산 (hexane) 추출물에 대한 모유두 세포의 증식 효과Proliferative effect of dermal papilla cells by hexane extract
상기 실시예 3과 동일한 방법으로 삼다차조 헥산 추출물에 대한 모유두 세포 증식 효과에 대해 실험을 수행하여, 하기 표 2 및 도 2에 나타내었다.Experiments were performed on the dermal papilla cell proliferation effect of the Samda perilla hexane extract in the same manner as in Example 3, and are shown in Table 2 and FIG. 2 below.
농도density | Cell proliferation (% of control)Cell proliferation (% of control) | |
대조군control group | -- | 100.0100.0 |
minoxidil (양성대조군)minoxidil (positive control) | 10 μM10 µM | 109.1109.1 |
삼다차조 hexane 추출물Samda tea hexane extract | 1 μg/mL1 µg/mL | 100.3±6.1100.3±6.1 |
삼다차조 hexane 추출물Samda tea hexane extract | 10 μg/mL10 µg/mL | 136.1±5.7136.1±5.7 |
삼다차조 hexane 추출물Samdachazo hexane extract | 25 μg/mL25 µg/mL | 125.4±4.9125.4±4.9 |
상기 표 2 및 도 2에 나타낸 바와 같이, 삼다차조 hexane 추출물을 1, 10 및 25 μg/mL의 농도로 처리하였을 때, 모유두 세포의 증식이 증가하는 것을 확인하였다. 특히, 삼다차조 hexane 추출물을 10 및 25 μg/mL의 농도로 처리한 경우, 대조군에 비하여 모유두 세포의 성장이 유의하게 증가하였으며, 양성대조군의 세포 증식 측정 결과보다 현저하게 높은 모유두 세포 증식 효과를 나타내었다.As shown in Table 2 and FIG. 2, it was confirmed that the proliferation of dermal papilla cells increased when the hexane extract of Samdachajo was treated at concentrations of 1, 10, and 25 μg/mL. In particular, when the hexane extract of Samda perilla extract was treated at concentrations of 10 and 25 μg/mL, the growth of dermal papilla cells increased significantly compared to the control group, and the dermal papilla cell proliferation effect was significantly higher than that of the positive control group. was
따라서, 삼다차조 헥산 추출물은 모유두 세포 증식 효능을 갖는 것을 알 수 있다.Therefore, it can be seen that the hexane extract of Samdachajo has the dermal papilla cell proliferation effect.
[실시예 5] [Example 5]
삼다차조 에틸아세테이트 (EtOAc) 추출물에 대한 모유두 세포의 증식 효과Proliferative effect of dermal papilla cell by Ethyl Acetate (EtOAc) extract
상기 실시예 3과 동일한 방법으로 삼다차조 에틸아세테이트 추출물에 대한 모유두 세포 증식 효과에 대해 실험을 수행하여, 하기 표 3 및 도 3에 나타내었다.In the same manner as in Example 3, an experiment was performed on the dermal papilla cell proliferation effect of the extract of Samda perilla ethyl acetate, and the results are shown in Table 3 and FIG. 3 below.
농도density | Cell proliferation (% of control)Cell proliferation (% of control) | |
대조군control group | -- | 100.0100.0 |
minoxidil (양성대조군)minoxidil (positive control) | 10 μM10 µM | 109.1109.1 |
삼다차조 EtOAc 추출물Samda |
1 μg/mL1 µg/mL | 100.7±2.2100.7±2.2 |
삼다차조 EtOAc 추출물Samda |
10 μg/mL10 µg/mL | 133.8±6.0133.8±6.0 |
삼다차조 EtOAc 추출물Samda |
25 μg/mL25 µg/mL | 127.9±7.1127.9±7.1 |
상기 표 3 및 도 3에 나타낸 바와 같이, 삼다차조 EtOAc 추출물을 1, 10 및 25 μg/mL의 농도로 처리하였을 때, 모유두 세포의 증식이 증가하는 것을 확인하였다. 특히, 삼다차조 EtOAc 추출물을 10 및 25 μg/mL의 농도로 처리한 경우, 대조군에 비하여 모유두 세포의 성장이 유의하게 증가하였으며, 양성대조군의 세포 증식 측정 결과보다 현저하게 높은 모유두 세포 증식 효과를 나타내었다.As shown in Table 3 and FIG. 3, when the EtOAc extract of Samdachajo was treated at concentrations of 1, 10, and 25 μg/mL, it was confirmed that the proliferation of dermal papilla cells increased. In particular, when the EtOAc extract of Samda perilla extract was treated at concentrations of 10 and 25 μg/mL, the growth of dermal papilla cells significantly increased compared to the control group, and the dermal papilla cell proliferation effect was significantly higher than that of the positive control group. was
따라서, 삼다차조 에틸아세테이트 추출물은 모유두 세포 증식 효능을 갖는 것을 알 수 있다.Therefore, it can be seen that the ethyl acetate extract of Samdachajo has a dermal papilla cell proliferation effect.
[실시예 6] [Example 6]
삼다차조 클로로포름 (CHClTertiary chloroform (CHCl
33
) 추출물에 대한 모유두 세포의 증식 효과) Proliferative effect of dermal papilla cells on the extract
상기 실시예 3과 동일한 방법으로 삼다차조 클로로포름 추출물에 대한 모유두 세포 증식 효과에 대해 실험을 수행하여, 하기 표 4 및 도 4에 나타내었다.In the same manner as in Example 3, experiments were performed on the dermal papilla cell proliferation effect of the chloroform extract of Samda perilla extract, and are shown in Table 4 and FIG. 4 below.
농도density | Cell proliferation (% of control)Cell proliferation (% of control) | |
대조군control group | -- | 100.0100.0 |
minoxidil (양성대조군)minoxidil (positive control) | 10 μM10 µM | 109.1109.1 |
삼다차조 CHCl3 추출물Samda Perilla CHCl 3 Extract | 1 μg/mL1 µg/mL | 110.6±7.6110.6±7.6 |
삼다차조 CHCl3 추출물Samda Perilla CHCl 3 Extract | 10 μg/mL10 µg/mL | 137.2±7.0137.2±7.0 |
삼다차조 CHCl3 추출물Samda Perilla CHCl 3 Extract | 25 μg/mL25 µg/mL | 127.5±6.1127.5±6.1 |
상기 표 4 및 도 4에 나타낸 바와 같이, 삼다차조 CHCl3 추출물을 1, 10 및 25 μg/mL의 농도로 처리하였을 때, 모유두 세포의 증식이 증가하는 것을 확인하였다. 특히, 삼다차조 CHCl3 추출물을 10 및 25 μg/mL의 농도로 처리한 경우, 대조군에 비하여 모유두 세포의 성장이 유의하게 증가하였으며, 양성대조군의 세포 증식 측정 결과보다 현저하게 높은 모유두 세포 증식 효과를 나타내었다.As shown in Table 4 and FIG. 4, it was confirmed that the proliferation of dermal papilla cells increased when the extract of Samdachajo CHCl 3 was treated at concentrations of 1, 10, and 25 μg/mL. In particular, when the Samda perilla CHCl 3 extract was treated at concentrations of 10 and 25 μg/mL, the growth of dermal papilla cells was significantly increased compared to the control group, and the dermal papilla cell proliferation effect was significantly higher than the cell proliferation measurement result of the positive control group. showed up
따라서, 삼다차조 클로로포름 추출물은 모유두 세포 증식 효능을 갖는 것을 알 수 있다.Therefore, it can be seen that the chloroform extract of Samda perilla has the dermal papilla cell proliferation effect.
[실시예 7] [Example 7]
삼다차조 부탄올 (BuOH) 추출물에 대한 모유두 세포의 증식 효과Proliferative effect of dermal papilla cells on trite perilla butanol (BuOH) extract
상기 실시예 3과 동일한 방법으로 삼다차조 부탄올 추출물에 대한 모유두 세포 증식 효과에 대해 실험을 수행하여, 하기 표 5 및 도 5에 나타내었다.In the same manner as in Example 3, experiments were performed on the dermal papilla cell proliferation effect of the butanol extract of Samda perilla extract, and are shown in Table 5 and FIG. 5 below.
농도density | Cell proliferation (% of control)Cell proliferation (% of control) | |
대조군control group | -- | 100.0100.0 |
minoxidil (양성대조군)minoxidil (positive control) | 10 μM10 µM | 109.1109.1 |
삼다차조 BuOH 추출물Samda |
1 μg/mL1 µg/mL | 101.3±7.8101.3±7.8 |
삼다차조 BuOH 추출물Samda |
10 μg/mL10 µg/mL | 134.8±5.9134.8±5.9 |
삼다차조 BuOH 추출물Samda |
25 μg/mL25 µg/mL | 142.3±6.0142.3±6.0 |
상기 표 5 및 도 5에 나타낸 바와 같이, 삼다차조 BuOH 추출물을 1, 10 및 25 μg/mL의 농도로 처리하였을 때, 농도가 증가할수록 모유두 세포의 증식이 증가하는 것을 확인하였다. 특히, 삼다차조 BuOH 추출물을 10 및 25 μg/mL의 농도로 처리한 경우, 대조군에 비하여 모유두 세포의 성장이 유의하게 증가하였으며, 양성대조군의 세포 증식 측정 결과보다 현저하게 높은 모유두 세포 증식 효과를 나타내었다.As shown in Table 5 and FIG. 5, when the BuOH extract of Samdachajo was treated at concentrations of 1, 10, and 25 μg/mL, it was confirmed that the proliferation of dermal papilla cells increased as the concentration increased. In particular, when the Samda perilla BuOH extract was treated at concentrations of 10 and 25 μg/mL, the growth of dermal papilla cells was significantly increased compared to the control group, and the dermal papilla cell proliferation effect was significantly higher than the cell proliferation measurement result of the positive control group. was
따라서, 삼다차조 부탄올 추출물은 모유두 세포 증식 효능을 갖는 것을 알 수 있다.Therefore, it can be seen that the butanol extract of Samdachajo has the dermal papilla cell proliferation effect.
[비교예 1] [Comparative Example 1]
삼다차조 열수 추출물에 대한 모유두 세포의 증식 효과Proliferative effect of dermal papilla cell on Samdachacha hot water extract
상기 실시예 3과 동일한 방법으로 삼다차조 열수 추출물에 대한 모유두 세포 증식 효과에 대한 실험을 수행하여, 하기 표 6 및 도 6에 나타내었다.In the same manner as in Example 3, an experiment was performed on the dermal papilla cell proliferation effect of the hot water extract of Samdacha algae, and the results are shown in Table 6 and FIG. 6 below.
농도density | Cell proliferation (% of control)Cell proliferation (% of control) | |
대조군control group | -- | 100.0100.0 |
minoxidil (양성대조군)minoxidil (positive control) | 10 μM10 µM | 107.0107.0 |
삼다차조 열수 추출물Samdachacha |
1 μg/mL1 µg/mL | 95.3±4.895.3±4.8 |
삼다차조 열수 추출물Samdachacha |
10 μg/mL10 µg/mL | 97.8±3.997.8±3.9 |
삼다차조 열수 추출물Samdachacha |
25 μg/mL25 µg/mL | 101.0±3.9101.0±3.9 |
상기 표 6 및 도 6에 나타낸 바와 같이, 삼다차조 열수 추출물을 1, 10 및 25 μg/mL의 농도로 처리하였을 때, 모유두 세포의 증식에 영향을 미치지 않는 것을 확인하였다. As shown in Table 6 and FIG. 6, it was confirmed that the proliferation of dermal papilla cells was not affected when the hot water extract of Samdachajo was treated at concentrations of 1, 10, and 25 μg/mL.
[비교예 2] [Comparative Example 2]
차조 70% 에탄올 (EtOH) 추출물에 대한 모유두 세포의 증식 효과Effect of 70% ethanol (EtOH) extract of perilla extract on the proliferation of dermal papilla cells
상기 실시예 3과 동일한 방법으로 차조 70% 에탄올 추출물에 대한 모유두 세포 증식 효과에 대한 실험을 수행하여, 하기 표 7 및 도 7에 나타내었다.Experiments on the dermal papilla cell proliferation effect of the 70% ethanol extract of perilla perilla in the same manner as in Example 3 were performed, and are shown in Table 7 and FIG. 7 below.
농도density | Cell proliferation (% of control)Cell proliferation (% of control) | |
대조군control group | -- | 100.0100.0 |
minoxidil (양성대조군)minoxidil (positive control) | 10 μM10 µM | 107.2107.2 |
차조 70% EtOH 추출물Perilla 70 |
1 μg/mL1 µg/mL | 103.4±3.5103.4±3.5 |
차조 70% EtOH 추출물Perilla 70 |
10 μg/mL10 µg/mL | 103.7±4.8103.7±4.8 |
차조 70% EtOH 추출물Perilla 70 |
25 μg/mL25 µg/mL | 101.9±1.2101.9±1.2 |
상기 표 7 및 도 7에 나타낸 바와 같이, 차조 70% EtOH 추출물을 1 및 10 μg/mL 농도로 처리하였을 때 모유두 세포의 증식을 증가시키는 것을 확인하였으나, 차조 70% EtOH 추출물을 25 μg/mL 농도로 처리하였을 때 저농도로 처리한 것과 비교하여 모유두 세포의 증식이 오히려 감소하는 것을 확인하였다.As shown in Table 7 and FIG. 7, it was confirmed that the proliferation of dermal papilla cells was increased when the 70% EtOH extract of perilla was treated at concentrations of 1 and 10 μg/mL, but the 70% EtOH extract of perilla at 25 μg/mL concentration When treated with, it was confirmed that the proliferation of dermal papilla cells rather decreased compared to that treated with a low concentration.
[비교예 3] [Comparative Example 3]
차조 열수 추출물에 대한 모유두 세포의 증식 효과Proliferative effect of dermal papilla cells on perilla hot water extract
상기 실시예 3과 동일한 방법으로 차조 열수 추출물에 대한 모유두 세포 증식 효과에 대한 실험을 수행하여, 하기 표 8 및 도 8에 나타내었다.Experiments on the dermal papilla cell proliferation effect of the perilla hot water extract were performed in the same manner as in Example 3, and are shown in Table 8 and FIG. 8 below.
농도density | Cell proliferation (% of control)Cell proliferation (% of control) | |
대조군control group | -- | 100.0100.0 |
minoxidil (양성대조군)minoxidil (positive control) | 10 μM10 µM | 109.1109.1 |
차조 열수 추출물Perilla |
1 μg/mL1 µg/mL | 99.4±3.599.4±3.5 |
차조 열수 추출물Perilla |
10 μg/mL10 µg/mL | 101.4±4.4101.4±4.4 |
차조 열수 추출물Perilla |
25 μg/mL25 µg/mL | 101.3±5.5101.3±5.5 |
상기 표 8 및 도 8에 나타낸 바와 같이, 차조 열수 추출물을 1, 10 및 25 μg/mL의 농도로 처리하였을 때, 모유두 세포의 증식에 영향을 미치지 않는 것을 확인하였다. As shown in Table 8 and FIG. 8, when the perilla hot water extract was treated at concentrations of 1, 10, and 25 μg/mL, it was confirmed that the proliferation of dermal papilla cells was not affected.
Claims (11)
- 삼다차조 추출물을 포함하는 탈모의 예방 또는 치료를 위한 약학 조성물.A pharmaceutical composition for the prevention or treatment of hair loss comprising an extract of cedar algae.
- 제1항에 있어서, 상기 삼다차조 추출물은 물, C1 내지 C6의 알코올, 에틸아세테이트, 헥산, 클로로포름, 및 이들의 혼합 용매로 이루어지는 군으로부터 선택되는 용매로 추출된 것을 특징으로 하는 탈모의 예방 또는 치료를 위한 약학 조성물.The prevention or treatment of hair loss according to claim 1, wherein the extract of Samdachajo is extracted with a solvent selected from the group consisting of water, C1 to C6 alcohol, ethyl acetate, hexane, chloroform, and mixed solvents thereof Pharmaceutical composition for.
- 제1항에 있어서, 상기 삼다차조 추출물은 0.01% 내지 90% 에탄올 추출물인 것을 특징으로 하는 탈모의 예방 또는 치료를 위한 약학 조성물.The pharmaceutical composition for the prevention or treatment of hair loss according to claim 1, wherein the samda perilla extract is a 0.01% to 90% ethanol extract.
- 제1항에 있어서, 상기 삼다차조 추출물은 60% 내지 80% 에탄올 추출물인 것을 특징으로 하는 탈모의 예방 또는 치료를 위한 약학 조성물.The pharmaceutical composition for the prevention or treatment of hair loss according to claim 1, wherein the samda perilla extract is a 60% to 80% ethanol extract.
- 제1항에 있어서, 상기 삼다차조 추출물은 70% 에탄올 추출물인 것을 특징으로 하는 탈모의 예방 또는 치료를 위한 약학 조성물.The pharmaceutical composition for the prevention or treatment of hair loss according to claim 1, wherein the ginseng extract is a 70% ethanol extract.
- 제1항에 있어서, 상기 삼다차조 추출물은 부탄올 추출물인 것을 특징으로 하는 탈모의 예방 또는 치료를 위한 약학 조성물.The pharmaceutical composition for the prevention or treatment of hair loss according to claim 1, wherein the samda perilla extract is a butanol extract.
- 제1항에 있어서, 상기 삼다차조 추출물은 모유두 세포의 증식을 증가시키는 것을 특징으로 하는 탈모의 예방 또는 치료를 위한 약학 조성물.The pharmaceutical composition for the prevention or treatment of hair loss according to claim 1, wherein the ginseng extract increases the proliferation of dermal papilla cells.
- 삼다차조 추출물을 포함하는 탈모의 예방 또는 개선을 위한 식품 조성물.A food composition for the prevention or improvement of hair loss comprising a cedar algae extract.
- 제8항 있어서, 상기 삼다차조 추출물은 물, C1 내지 C6의 알코올, 에틸아세테이트, 헥산, 클로로포름, 및 이들의 혼합 용매로 이루어지는 군으로부터 선택되는 용매로 추출된 것을 특징으로 하는 탈모의 예방 또는 개선를 위한 식품 조성물.The method of claim 8, wherein the Samdachajo extract is extracted with a solvent selected from the group consisting of water, C1 to C6 alcohol, ethyl acetate, hexane, chloroform, and mixed solvents thereof. For preventing or improving hair loss, characterized in that food composition.
- 제8항에 있어서, 상기 삼다차조 추출물은 0.01% 내지 90% 에탄올 추출물인 것을 특징으로 하는 탈모의 예방 또는 개선을 위한 식품 조성물.[Claim 9] The food composition for preventing or improving hair loss according to claim 8, wherein the extract of Samdachajo is 0.01% to 90% ethanol extract.
- 제8항에 있어서, 상기 삼다차조 추출물은 부탄올 추출물인 것을 특징으로 하는 탈모의 예방 또는 개선을 위한 식품 조성물.[Claim 9] The food composition for the prevention or improvement of hair loss according to claim 8, wherein the samda perilla extract is a butanol extract.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2021-0134050 | 2021-10-08 | ||
KR1020210134050A KR20230050806A (en) | 2021-10-08 | 2021-10-08 | A composition for prevention or treatment of hair loss comprising setaria italica beauv. extract |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023059047A1 true WO2023059047A1 (en) | 2023-04-13 |
Family
ID=85803610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2022/014951 WO2023059047A1 (en) | 2021-10-08 | 2022-10-05 | Composition for preventing or treating hair loss, comprising samdachal-jo (jeju glutinous millet) extract |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20230050806A (en) |
WO (1) | WO2023059047A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008520588A (en) * | 2004-11-18 | 2008-06-19 | ビオファーマコペ デジン アンテルナショナル インク. | Plant extract and its dermatological usage |
KR20190037777A (en) * | 2017-09-29 | 2019-04-08 | 유씨엘 주식회사 | Cosmetic composition for preventing seborrheic dematitis and hair loss |
KR20200091361A (en) * | 2019-01-22 | 2020-07-30 | 이동완 | Compositions for promoting hair growth or preventing hair loss comprising a complex extract of cucumber, eggplant and snail |
KR20210012169A (en) * | 2019-07-24 | 2021-02-03 | 주식회사 바이오원코리아 | Food composition for hair-loss and hair-growth comprising herbal medicine and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102150927B1 (en) | 2018-12-31 | 2020-09-02 | 대봉엘에스 주식회사 | Cosmetic and pharmaceutical compositin comprising sasa quelpaertensis extract and urea |
-
2021
- 2021-10-08 KR KR1020210134050A patent/KR20230050806A/en not_active Application Discontinuation
-
2022
- 2022-10-05 WO PCT/KR2022/014951 patent/WO2023059047A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008520588A (en) * | 2004-11-18 | 2008-06-19 | ビオファーマコペ デジン アンテルナショナル インク. | Plant extract and its dermatological usage |
KR20190037777A (en) * | 2017-09-29 | 2019-04-08 | 유씨엘 주식회사 | Cosmetic composition for preventing seborrheic dematitis and hair loss |
KR20200091361A (en) * | 2019-01-22 | 2020-07-30 | 이동완 | Compositions for promoting hair growth or preventing hair loss comprising a complex extract of cucumber, eggplant and snail |
KR20210012169A (en) * | 2019-07-24 | 2021-02-03 | 주식회사 바이오원코리아 | Food composition for hair-loss and hair-growth comprising herbal medicine and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
RAON: "The Grains of Raon - Types and Effects of Setaria italica Beauv. 라온의 곡류 – 차조의 종류 및 효능", NAVER BLOG, 29 March 2021 (2021-03-29), Retrieved from the Internet <URL:https://blog.naver.com/laonwhoje/222291307403> * |
Also Published As
Publication number | Publication date |
---|---|
KR20230050806A (en) | 2023-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010134756A2 (en) | Composition comprising green tea extract | |
WO2015137652A1 (en) | 5-alpha reductase inhibiting fermented camellia japonica seed oil for alleviating benign prostatic hypertrophy and baldness | |
WO2015002391A1 (en) | Composition having a function for alleviating premenstrual syndrome and menstrual pain | |
WO2014058142A1 (en) | Pharmaceutical composition containing aster glehni extract as active ingredientfor preventing or treating obesity or metabolic diseases | |
WO2016182225A1 (en) | Composition for preventing hair loss and growing hair | |
WO2018117725A1 (en) | Composition for preventing hair loss and promoting hair growth, comprising fermented marine animal products | |
WO2018105926A1 (en) | Anti-allergy composition containing lactobacillus-fermented composite medicinal herb extract as active ingredient | |
WO2015108394A1 (en) | Cosmetic composition containing hydroxy pyranone derivative compound for promoting differentiation of adipocytes | |
WO2018043874A1 (en) | Composition, for preventing hair loss or promoting hair growth, comprising strains showing lipolysis effect | |
WO2020040432A1 (en) | Pharmaceutical composition for preventing or treating muscle diseases, containing ginseng berry extract as active ingredient | |
WO2016056781A1 (en) | Composition for hair loss prevention or hair growth stimulation comprising artemisia umbelliformis extract | |
WO2023059047A1 (en) | Composition for preventing or treating hair loss, comprising samdachal-jo (jeju glutinous millet) extract | |
WO2023022540A1 (en) | Composition for preventing hair loss or promoting hair growth comprising milk thistle flower extract as active ingredient | |
WO2016056780A1 (en) | Composition for hair loss prevention or hair growth stimulation comprising scutellaria alpina extract | |
WO2013115456A1 (en) | Food, cosmetic material, or pharmaceutical composition containing ginger supercritical extract and fermented dropwort residue extract | |
WO2015167240A1 (en) | Composition containing scutellaria alpina extract | |
WO2019139403A1 (en) | Composition containing sericin, torilis japonica extract, and viscum album extract for skin generation, skin soothing, or wound healing | |
WO2021215882A1 (en) | Composition for preventing hair loss or promoting hair growth comprising camellia pericarp extract as active ingredient | |
WO2023059053A1 (en) | Composition for preventing or alleviating hair loss, comprising extract of samda glutinous foxtail millet | |
KR101273027B1 (en) | Composition for inhibiting sebum secretion and anti-obesity comprising kaempferol | |
WO2016003120A1 (en) | Whitening composition comprising scutellaria alpina extract | |
WO2019164090A1 (en) | Composition containing skunk cabbage extract or fraction thereof as active ingredient for wrinkle relief | |
WO2014133276A1 (en) | Composition containing, as active ingredients, menispermum dauricum, extract of menispermum dauricum, slime of menispermum dauricum, or extract of malt enzyme liquid of menispermum dauricum for preventing or treating anorexia | |
WO2024014663A1 (en) | Pharmaceutical composition for preventing or treating alopecia including akkermansia | |
WO2020130198A1 (en) | Composition for preventing, alleviating, or treating stress and depression comprising medicinal herb complex extract as active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22878868 Country of ref document: EP Kind code of ref document: A1 |